There are still a lot of challenges facing pharmaceuticals, med tech, and biotech companies that seek to begin a clinical trial post-COVID. But the obstacles aren’t stopping them. At time of writing, over 500 companies have a Phase II or Phase III clinical trial startup planned in the next 12
The decentralized clinical trial is one of the most talked-about emerging trends in the life sciences industry. These sorts of clinical trials present immense benefits, as we wrote about in a recent blog.
If executed well, the decentralized clinical trial design could both reduce resource consumption and accelerate treatments arrival to
Krystyna Kowalczyk joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss innovation and leadership in oncology clinical trials.
The founder and CEO of OncoBay Clinical, Krystyna shares her efforts to break the mold when it comes to cancer research, and explores OncoBay's "just in time"
We recently spoke with Liz Beatty, Chief Strategy Officer at Inato about how the company is disrupting the industry's approach to site selection. The company is headquartered in Paris, France, with US operations based in New York City, NY. Here are some of the most interesting excerpts from our discussion:
Along with most major clinical operations conferences, the Outsourcing in Clinical Trials event series is virtual in 2021.
The ArcheMedX team is excited to exhibit - as we join some of the foremost thought leaders at the leading clinical outsourcing and operations conference on the West Coast.
ArcheMedX team members will be
Choosing the right way to train clinical trial staff is complex and exhausting under normal circumstances. Today’s immense pressure to accommodate new virtual working styles across investigator meetings, site selection, and site initiation visits magnifies those challenges.
As we revealed in our recent report, clinical operations leaders are adopting virtual tools
Paul Evans of Velocity Clinical Research talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, to discuss best practices for sites making the shift toward decentralized trials.
Paul shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to
Mary Costello talks with Kelly Ritch, EVP of Product and Clinical Research Solutions, about how clinical research site management is changing - and marching towards sites being capable with decentralized clinical trials - in the face of the pandemic.
Mary’s more than 20 years of diverse experience in the
R'Kes Starling joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss how decentralized clinical trials (DCTs) can expand access to clinical trials and promote patient participation. He shares the personal experiences that motivated him to found Reveles.
R'Kes also recounts a poignant story of a